Recombinant COVID-19 antigen-human soluble ACE2 protein
(soluble hACE2, extracellular hACE2, C-FC)

Cat No.: GMP-H-ACE2002

Order information

Package Catalog No. Price(In USD) Qty (Quantity) Sum(In USD)
1mg GMP-H-ACE2002-1mg 5990
10mg GMP-H-ACE2002-10mg 38790
100mg GMP-H-ACE2002-100mg 258000
≥100mg GMP-H-ACE2002-xmg Inquiry
Shipping Cost: 760.00


Accession Number Q9BYF1
Expression platform Human
Isotypesmammalian (human cell)
Products description Recombinant human soluble ACE2 protein (ACE2,Angiotensin-converting enzyme 2) was expressed
in mammalian cell (human cells)expression system with a His tag at the C-terminus. The target
gene encoding 723 amino acids (Gln18-Ser740) of human ACE2 extracellular domain is expressed with
human Fc tag at the C-terminus.
Bioactivity validationSpike(S-RBD) protein binding
PurityPurity: ≥95%(SDS-PAGE)
Application spike protein-hACE2 binding inhibition assay used in neutralizing antibody,
peptide inhibitor, lead compounds and vaccines development against COVID-19
predicted Molecular Mass109.2kD
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

GeneMedi's Spike protein & ACE2-Fc Binding Validation In Sandwich ELISA

Picture loading failed.

Figure. GeneMedi's ACE2-Fc(GMP-H-ACE2002) binding validation with Spike protein (

GMP-V-2019nCoV-SRBD001) and (

GMP-V-2019nCoV-S1S2001) in sandwich ELISA.

Email: [email protected]   [email protected]
Telephone: +86-21-50478399   Fax: 86-21-50478399
Privacy Policy